JNJ logo

Johnson & Johnson (JNJ) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

02 January 1943

Description:

Johnson & Johnson is an American corporation consisting of three major divisions: consumer products, pharmaceuticals, and medical devices. Founded in 1886, the headquarters are in New Jersey. Johnson & Johnson produces a wide range of pharmaceuticals, body care products under the brand names JOHNSON'S Baby, Neutrogena, o.b., Carefree, Reach, Clean & Clear, RoC, Acuvue contact lenses, and others. The company also manufactures various materials, instruments, equipment, and technologies for medical institutions. It has more than 250 subsidiaries in over 60 countries and its products are sold in more than 175 countries.

Key Details

Price

$144.65

TTM Dividend Yield

2.54%(-15.33% YoY)

PE Ratio

23.91(+111.03% YoY)

Beta

-0.05

Events Calendar

Earnings

Next earnings date:

Jan 22, 2025

Recent quarterly earnings:

Oct 15, 2024

Recent annual earnings:

Jan 23, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Aug 27, 2024
Splits

Next split:

N/A

Recent split:

June 13, 2001

Analyst ratings

Recent major analysts updates

11 Dec '24 Citigroup
Buy
15 Nov '24 Wolfe Research
Outperform
06 Nov '24 Guggenheim
Neutral
16 Oct '24 Wells Fargo
Equal-Weight
16 Oct '24 RBC Capital
Outperform
16 Oct '24 Morgan Stanley
Equal-Weight
16 Oct '24 Citigroup
Buy
16 Oct '24 Cantor Fitzgerald
Overweight
10 Oct '24 Cantor Fitzgerald
Overweight
08 Oct '24 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
JNJ
zacks.com01 January 2025

Johnson & Johnson (JNJ) has a strong track record of surprising with its earnings and currently has the right mix of factors that could lead to a positive outcome in its upcoming quarterly report.

The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
JNJ
TheStreet01 January 2025

The companies that have lost the most value in the Dow are from the aerospace, biopharmaceutical, and sports clothing industries.

Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
JNJ
zacks.com31 December 2024

On the most recent trading day, Johnson & Johnson (JNJ) closed at $144.62, which is an increase of 0.89% compared to its last closing price.

J&J Trading Near 52-Week Low: Should You Sell the Stock?
J&J Trading Near 52-Week Low: Should You Sell the Stock?
J&J Trading Near 52-Week Low: Should You Sell the Stock?
JNJ
zacks.com30 December 2024

Stockholders might choose to keep their investments for a while since J&J is hopeful about improving results in 2025.

Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
JNJ
benzinga.com27 December 2024

Johnson & Johnson (JNJ), a well-known healthcare company recognized for its reliable dividends and defensive qualities, has recently formed a bearish technical pattern called the Death Cross.

JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723
JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723
JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723
JNJ
zacks.com27 December 2024

Johnson & Johnson has revealed a worldwide licensing agreement with Kaken for its eczema treatment, KP-723, to enhance its dermatology offerings.

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
JNJ
zacks.com26 December 2024

Lately, users of Zacks.com have been focusing on Johnson & Johnson (JNJ). This interest prompts a closer look at what the stock might offer.

Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks
Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks
Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks
JNJ
fool.com24 December 2024

Stocks that pay dividends are a great source of ongoing income. They provide you with regular payments that you can use to invest further or help with your bills.

Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note
Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note
Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note
JNJ
zacks.com23 December 2024

In the latest trading session, Johnson & Johnson (JNJ) finished at $145.27, showing an increase of 0.55% compared to the day before.

Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?
Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?
Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?
JNJ
Insider Monkey19 December 2024

We have put together a list of the 10 Dogs of the Dow Dividend Stocks to consider for investment. In this article, we will examine how Johnson & Johnson (NYSE:JNJ) compares to other dividend stocks. Investors who focus on dividends usually prefer stocks with high yields and base their strategies on these types of investments.

FAQ

  • What is the primary business of Johnson & Johnson?
  • What is the ticker symbol for Johnson & Johnson?
  • Does Johnson & Johnson pay dividends?
  • What sector is Johnson & Johnson in?
  • What industry is Johnson & Johnson in?
  • What country is Johnson & Johnson based in?
  • When did Johnson & Johnson go public?
  • Is Johnson & Johnson in the S&P 500?
  • Is Johnson & Johnson in the NASDAQ 100?
  • Is Johnson & Johnson in the Dow Jones?
  • When was Johnson & Johnson's last earnings report?
  • When does Johnson & Johnson report earnings?
  • Should I buy Johnson & Johnson stock now?

What is the primary business of Johnson & Johnson?

Johnson & Johnson is an American corporation consisting of three major divisions: consumer products, pharmaceuticals, and medical devices. Founded in 1886, the headquarters are in New Jersey. Johnson & Johnson produces a wide range of pharmaceuticals, body care products under the brand names JOHNSON'S Baby, Neutrogena, o.b., Carefree, Reach, Clean & Clear, RoC, Acuvue contact lenses, and others. The company also manufactures various materials, instruments, equipment, and technologies for medical institutions. It has more than 250 subsidiaries in over 60 countries and its products are sold in more than 175 countries.

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is NYSE:JNJ

Does Johnson & Johnson pay dividends?

Yes, Johnson & Johnson pays dividends. The last payment was $1.24, with an ex-dividend date on 27 August 2024

What sector is Johnson & Johnson in?

Johnson & Johnson is in the Healthcare sector

What industry is Johnson & Johnson in?

Johnson & Johnson is in the Drug Manufacturers - General industry

What country is Johnson & Johnson based in?

Johnson & Johnson is headquartered in United States

When did Johnson & Johnson go public?

Johnson & Johnson's initial public offering (IPO) was on 02 January 1943

Is Johnson & Johnson in the S&P 500?

Yes, Johnson & Johnson is included in the S&P 500 index

Is Johnson & Johnson in the NASDAQ 100?

No, Johnson & Johnson is not included in the NASDAQ 100 index

Is Johnson & Johnson in the Dow Jones?

Yes, Johnson & Johnson is included in the Dow Jones index

When was Johnson & Johnson's last earnings report?

Johnson & Johnson's most recent earnings report was on 15 October 2024

When does Johnson & Johnson report earnings?

The next expected earnings date for Johnson & Johnson is 22 January 2025

Should I buy Johnson & Johnson stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions